Status:
COMPLETED
Testing Performance and Usability of Q300 Device
Lead Sponsor:
QART Medical
Conditions:
Healthy
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
A data collection clinical study performed on live human spermatozoa samples. Spermatozoa are imaged by QART Q300TM microscopy system. For the feasibility 1st phase of the study, up to 75 donors are e...
Detailed Description
Cells will be individually selected by the system, and will be representative of the cell population to be selected in ICSI procedures. Each selected cell will be imaged by the QART system and indepen...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Patients recruited from the hospital's andrology/IVF departments
- Male, Age \>18
- Patient signed on informed consent
Exclusion
- Severe Oligozoospermia (less than 1 million sperm cells after preparation).
- Documented presence of infectious disease transmitted in sperm fluids (e.g. HIV, HBV, HCV, Covid-19)
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2023
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04901572
Start Date
September 1 2021
End Date
April 4 2023
Last Update
June 29 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Barzilai Medical Center
Ashkelon, Israel
2
Wolfson Medical Center
Holon, Israel
3
Shaare Zedek Medical Center
Jerusalem, Israel
4
Meir Medical Center
Kfar Saba, Israel